ZEB1 and non-small cell lung carcinoma: Regarding genes that predict the response to oxaliplatin-based chemotherapy, upregulation of SNAIL, SLUG and ZEB1/ZEB2 have been linked to overexpression of ERCC1 in colon cancer, head and neck cancer, and NSCLC cell lines, which was associated with cisplatin resistance (another platinum derivative) in the latter [33,34,35].